ES2523016A1 - Vectores alfavirales y líneas celulares para la producción de proteínas recombinantes - Google Patents
Vectores alfavirales y líneas celulares para la producción de proteínas recombinantes Download PDFInfo
- Publication number
- ES2523016A1 ES2523016A1 ES201330722A ES201330722A ES2523016A1 ES 2523016 A1 ES2523016 A1 ES 2523016A1 ES 201330722 A ES201330722 A ES 201330722A ES 201330722 A ES201330722 A ES 201330722A ES 2523016 A1 ES2523016 A1 ES 2523016A1
- Authority
- ES
- Spain
- Prior art keywords
- interest
- cell lines
- alphaviral vectors
- recombinant proteins
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36141—Use of virus, viral particle or viral elements as a vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Vectores alfavirales y líneas celulares para la producción de proteínas recombinantes. La presente invención se relaciona con polinucleótidos y vectores alfavirales para la expresión de genes de interés en células de mamífero. Adicionalmente, la invención se relaciona con células que comprenden dichos polinucleótidos y vectores alfavirales, y que son capaces de expresar de forma estable uno o más genes de interés. La invención también se relaciona con métodos para obtener dichas células, con métodos para expresar un gen de interés en dichas células, y con métodos para reemplazar el gen de interés que dichas células expresan de forma estable por otro gen de interés.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES201330722A ES2523016B1 (es) | 2013-05-20 | 2013-05-20 | Vectores alfavirales y líneas celulares para la producción de proteínas recombinantes |
PCT/ES2014/070416 WO2014188042A1 (es) | 2013-05-20 | 2014-05-20 | Vectores alfavirales y líneas celulares para la producción de proteínas recombinantes |
ES14801304T ES2759916T3 (es) | 2013-05-20 | 2014-05-20 | Vectores alfavirales y líneas celulares para la producción de proteínas recombinantes |
EP14801304.8A EP3000890B1 (en) | 2013-05-20 | 2014-05-20 | Alphaviral vectors and cell lines for producing recombinant proteins |
US14/892,829 US10011847B2 (en) | 2013-05-20 | 2014-05-20 | Alphaviral vectors and cell lines for producing recombinant proteins |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES201330722A ES2523016B1 (es) | 2013-05-20 | 2013-05-20 | Vectores alfavirales y líneas celulares para la producción de proteínas recombinantes |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2523016A1 true ES2523016A1 (es) | 2014-11-20 |
ES2523016B1 ES2523016B1 (es) | 2015-09-09 |
Family
ID=51899033
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES201330722A Expired - Fee Related ES2523016B1 (es) | 2013-05-20 | 2013-05-20 | Vectores alfavirales y líneas celulares para la producción de proteínas recombinantes |
ES14801304T Active ES2759916T3 (es) | 2013-05-20 | 2014-05-20 | Vectores alfavirales y líneas celulares para la producción de proteínas recombinantes |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES14801304T Active ES2759916T3 (es) | 2013-05-20 | 2014-05-20 | Vectores alfavirales y líneas celulares para la producción de proteínas recombinantes |
Country Status (4)
Country | Link |
---|---|
US (1) | US10011847B2 (es) |
EP (1) | EP3000890B1 (es) |
ES (2) | ES2523016B1 (es) |
WO (1) | WO2014188042A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020181058A1 (en) * | 2019-03-05 | 2020-09-10 | Massachusetts Institute Of Technology | Dna launched rna replicon system (drep) and uses thereof |
MX2022015772A (es) | 2020-06-09 | 2023-05-19 | Inozyme Pharma Inc | Proteínas enpp1 o enpp3 solubles y sus usos. |
CN112143755A (zh) * | 2020-10-19 | 2020-12-29 | 深圳市瑞普逊科技有限公司 | 一种人甲状旁腺激素真核表达重组质粒载体及其构建方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011064437A2 (es) * | 2009-11-26 | 2011-06-03 | Proyecto De Biomedicina Cima, S.L. | Vectores virales y procedimientos útiles en la preparación de gdnf |
WO2012001196A2 (es) * | 2010-06-28 | 2012-01-05 | Proyecto De Biomedicina Cima, S.L. | Vectores alfavirales y usos de los mismos para la expresión de genes heterólogos |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986004920A1 (en) | 1985-02-13 | 1986-08-28 | Biotechnology Research Partners, Limited | Human metallothionein-ii promoter in mammalian expression system |
US5866755A (en) | 1993-06-14 | 1999-02-02 | Basf Aktiengellschaft | Animals transgenic for a tetracycline-regulated transcriptional inhibitor |
GB9326271D0 (en) | 1993-12-23 | 1994-02-23 | Zeneca Ltd | Expression of self-processing polyprotein in transgenic plants |
DE69638321D1 (de) | 1995-10-11 | 2011-03-03 | Luminex Corp | Gleichzeitige mehrfachanalyse klinischer proben |
EP0910652B1 (en) | 1996-04-05 | 2014-10-08 | The Salk Institute For Biological Studies | Hormone-mediated methods for modulating expression of exogenous genes in mammalian systems, and products related thereto |
EP1997900A3 (en) | 1996-04-05 | 2010-10-06 | Novartis Vaccines and Diagnostics, Inc. | Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
US6451592B1 (en) | 1996-04-05 | 2002-09-17 | Chiron Corporation | Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
US6534314B1 (en) | 1996-06-14 | 2003-03-18 | Massachusetts Institute Of Technology | Methods and compositions for transforming cells |
US6057134A (en) | 1996-10-07 | 2000-05-02 | Ambion, Inc. | Modulating the efficiency of nucleic acid amplification reactions with 3' modified oligonucleotides |
CA2281205A1 (en) | 1997-02-12 | 1998-08-13 | Eugene Y. Chan | Methods and products for analyzing polymers |
US6365731B1 (en) | 1997-08-06 | 2002-04-02 | Ambion, Inc. | Stripping nucleic acids with iodine and sodium thiosulfate |
JP4357112B2 (ja) | 1997-10-14 | 2009-11-04 | ルミネックス コーポレイション | 精密蛍光染色された粒子及びその製造及び使用方法 |
JP4206154B2 (ja) | 1997-11-13 | 2009-01-07 | 大日本住友製薬株式会社 | 変異型loxP配列とその応用 |
JP2002521461A (ja) | 1998-07-29 | 2002-07-16 | インビトロゲン・コーポレーション | Rnaウイルスを用いる組換えタンパク質の調節発現 |
US6458583B1 (en) | 1998-09-09 | 2002-10-01 | Agilent Technologies, Inc. | Method and apparatus for making nucleic acid arrays |
US6461812B2 (en) | 1998-09-09 | 2002-10-08 | Agilent Technologies, Inc. | Method and multiple reservoir apparatus for fabrication of biomolecular arrays |
US6436640B1 (en) | 1999-03-18 | 2002-08-20 | Exiqon A/S | Use of LNA in mass spectrometry |
WO2000060091A2 (en) | 1999-04-06 | 2000-10-12 | Oklahoma Medical Research Foundation | Method for selecting recombinase variants with altered specificity |
US6287813B1 (en) | 1999-04-23 | 2001-09-11 | Cistronics Cell Technology Gmbh | Antibiotic-based gene regulation system |
US6465183B2 (en) | 1999-07-01 | 2002-10-15 | Agilent Technologies, Inc. | Multidentate arrays |
US6461816B1 (en) | 1999-07-09 | 2002-10-08 | Agilent Technologies, Inc. | Methods for controlling cross-hybridization in analysis of nucleic acid sequences |
AU6779700A (en) | 1999-08-17 | 2001-03-13 | Luminex Corporation | Microparticles with multiple fluorescent signals and methods of using same |
US7122303B2 (en) | 1999-09-17 | 2006-10-17 | Agilent Technologies, Inc. | Arrays comprising background features that provide for a measure of a non-specific binding and methods for using the same |
US6428957B1 (en) | 1999-11-08 | 2002-08-06 | Agilent Technologies, Inc. | Systems tools and methods of assaying biological materials using spatially-addressable arrays |
AU1647501A (en) * | 1999-12-10 | 2001-06-18 | Cytos Biotechnology Ag | Replicon based activation of endogenous genes |
WO2001081553A1 (en) | 2000-04-25 | 2001-11-01 | Chiron Corporation | Alphavirus-based vectors for persistent infection |
US6750015B2 (en) | 2000-06-28 | 2004-06-15 | Kathryn B. Horwitz | Progesterone receptor-regulated gene expression and methods related thereto |
AU2002334307A1 (en) | 2001-09-04 | 2003-03-18 | Exiqon A/S | Novel lna compositions and uses thereof |
DE10148294C1 (de) | 2001-09-29 | 2003-01-16 | Unicor Rohrsysteme Gmbh | Formbackenhälfte für einen Corrugator zum Herstellen von Querrippenrohren |
EP1534737A4 (en) | 2002-04-29 | 2007-10-31 | Univ Saint Louis | PEPTIDE ANTAGONISTS OF TGF-BETA FAMILY ELEMENTS AND THERAPEUTIC USES OF THESE ANTAGONISTS |
ES2304069B1 (es) | 2003-08-22 | 2009-08-12 | Proyecto De Biomedicina Cima, S.L. | Peptidos con capacidad de unirse al factor transformante de crecimiento beta 1 (tgf-b1). |
ES2292271B1 (es) | 2004-05-20 | 2009-02-16 | Proyecto De Biomedicina Cima, S.L. | Un vector hibrido adenovirus-alfavirus para la administracion eficaz y expresion de genes terapeuticos en celulas tumorales. |
JP2009524406A (ja) | 2005-10-13 | 2009-07-02 | ビーシー キャンサー エージェンシー | 合成生物学および代謝工学のためのモジュラー型ゲノム |
GR20060100496A (el) * | 2006-09-01 | 2008-04-15 | Παρθενιος Μπουλικας | ΛΙΠΟΣΩΜΑΤΙΚΑ ΕΓΚΑΨΥΛΙΩΜΕΝΟΙ ΦΟΡΕΙΣ-ΥΒΡΙΔΙΟΥ ΑΔΕΝΟΙΟΥ - ΙΟΥ SEMLIKI FOREST (SFV), ΠΟΥ ΦΕΡΕΙ ΚΑΤΑΣΚΕΥΑΣΜΑΤΑ RNAi ΚΑΙ ΘΕΡΑΠΕΥΤΙΚΑ ΓΟΝΙΔΙΑ ΠΟΥ ΧΡΗΣΙΜΟΠΟΙΟΥΝΤΑΙ ΕΝΑΝΤΙΟΝ ΣΤΟΧΩΝ ΚΑΡΚΙΝΟΥ ΚΑΙ ΑΛΛΩΝ ΑΣΘΕΝΕΙΩΝ |
RS51484B (en) | 2006-11-28 | 2011-04-30 | Proyecto De Biomedicina Cima, S.L. | VIRAL VECTOR AND USES OF THE SAME |
-
2013
- 2013-05-20 ES ES201330722A patent/ES2523016B1/es not_active Expired - Fee Related
-
2014
- 2014-05-20 WO PCT/ES2014/070416 patent/WO2014188042A1/es active Application Filing
- 2014-05-20 US US14/892,829 patent/US10011847B2/en active Active
- 2014-05-20 EP EP14801304.8A patent/EP3000890B1/en active Active
- 2014-05-20 ES ES14801304T patent/ES2759916T3/es active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011064437A2 (es) * | 2009-11-26 | 2011-06-03 | Proyecto De Biomedicina Cima, S.L. | Vectores virales y procedimientos útiles en la preparación de gdnf |
WO2012001196A2 (es) * | 2010-06-28 | 2012-01-05 | Proyecto De Biomedicina Cima, S.L. | Vectores alfavirales y usos de los mismos para la expresión de genes heterólogos |
Non-Patent Citations (6)
Title |
---|
GEISS, B.J. et al., `Recombination-ready Sindbis replicon expression vectors for transgene expression¿, VIROLOGY JOURNAL, 2007, Vol. 4, Página 112, ISSN: 1743-422X (Electronic), doi: 10.1186/1743-422X-4-112, Materiales y Métodos, Figura 1. * |
KARLSSON, G.B. et al., `Delivery and expression of heterologous genes in mammalian cells using self-replicating alphavirus vectors¿, METHODS MOL. BIOL., 2004, Vol. 246, Páginas 543-557, ISSN: 1064-3745 (Print), todo el documento. * |
QUETGLAS, J.I. et al., `Alphavirus vectors for cancer therapy¿, VIRUS RESEARCH, 2010 Nov, Vol. 153, No. 2, Páginas 179-196, ISSN: 0168-1702, doi: 10.1016/j.virusres.2010.07.027, todo el documento. * |
RIEZEBOS-BRILMAN, A. et al., `Recombinant alphaviruses as vectors for anti-tumour and anti-microbial immunotherapy¿, JOURNAL OF CLINICAL VIROLOGY, 2006, Vol. 35, No. 3, Páginas 233-243, ISSN: 1386-6532 (Print), todo el documento. * |
STEEL, J.J. et al., `Infectious alphavirus production from a simple plasmid transfection+¿, VIROLOGY JOURNAL, 2011, Vol. 8, Página 356, ISSN: 1743-422X (Electronic), doi: 10.1186/1743-422X-8-356, Métodos, Figura 1. * |
WANG, Y. et al., `Recombinase technology: applications and possibilities¿, Plant Cell Reports, 2011, Vol. 30, No. 3, Páginas 267-285, ISSN: 0721-7714, todo el documento. * |
Also Published As
Publication number | Publication date |
---|---|
ES2759916T3 (es) | 2020-05-12 |
US10011847B2 (en) | 2018-07-03 |
WO2014188042A1 (es) | 2014-11-27 |
ES2523016B1 (es) | 2015-09-09 |
EP3000890B1 (en) | 2019-08-14 |
EP3000890A1 (en) | 2016-03-30 |
EP3000890A4 (en) | 2017-02-01 |
US20160208286A1 (en) | 2016-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112016025519A2 (pt) | engenharia genética in vivo com vetores de adenovírus | |
SG10201803758XA (en) | Enhanced Transgene Expression and Processing | |
MX2018010529A (es) | Composiciones y metodos para la produccion y administracion de acido ribonucleico. | |
MX2019002498A (es) | Metodos y productos para la expresion de proteinas en celulas. | |
SG10201806498RA (en) | Cultured mammalian limbal stem cells, methods for generating the same, and uses thereof | |
MX2019013498A (es) | Receptor de antigeno quimerico y metodos para usarlo. | |
MX2019005158A (es) | Variantes de glucoamilasa y polinucleotidos que las codifican. | |
MX371025B (es) | Células eucariotas novedosas y métodos para la expresión recombinante de un producto de interés. | |
MX2018014043A (es) | Composiciones de cultivo celular con antioxidantes y metodos para la produccion de polipeptidos. | |
MX355356B (es) | Variantes de alfa-amilasa y polinucleotidos que codifican las mismas. | |
MX2014004539A (es) | Variantes de alfa-amilasa y polinucleotidos que codifican las mismas. | |
MX2016008258A (es) | Celulas eucariotas novedosas y metodos para la expresion recombinante de un producto de interes. | |
HK1200848A1 (en) | Expression vector element combinations, novel production cell generation methods and their use for the recombinant production of polypeptides | |
EP2935581A4 (en) | EXPRESSION VECTORS FOR THE PRODUCTION OF RECOMBINANT PROTEINS IN MAMMALIAN CELLS | |
WO2016007570A3 (en) | Engineered invariant natural killer t (inkt) cells and methods of making and using thereof | |
MX2016001396A (es) | Seleccion novedosa de vectores y metodos de seleccion de celulas hospederas eucarioticas. | |
MX2016011465A (es) | Drimenol-sintasas y metodos para producir drimenol. | |
HK1250743A1 (zh) | 表達載體組織、新的生產用細胞產生方法及其在重組產生多肽中的用途 | |
GB201113499D0 (en) | Expression of transcription factor encoding genes | |
ES2523016A1 (es) | Vectores alfavirales y líneas celulares para la producción de proteínas recombinantes | |
MX2017005295A (es) | Marcador de seleccion novedoso para transfeccion celular y produccion de proteinas. | |
MY198268A (en) | Omega-hydroxylase-related fusion polypeptides with improved properties | |
MX2016013955A (es) | Drimenol-sintasas y metodo de produccion de drimenol. | |
SG11201600682PA (en) | Expression vector for production of recombinant proteins in prokaryotic host cells | |
MX2016005572A (es) | Uso de monensina para regular la glicosilacion de proteinas recombinantes. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 2523016 Country of ref document: ES Kind code of ref document: B1 Effective date: 20150909 |
|
FD2A | Announcement of lapse in spain |
Effective date: 20211004 |